ETENDERS

Contract award notice

Information

Published

Date of dispatch of this notice: 09/03/2020

External Reference: 2020-222269

TED Reference: 2020/S 050-118532

Contract award notice

Contract award notice

Results of the procurement procedure

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

Children's Health Ireland
N/A
Dublin 12
Dublin
Ireland
IE
Contact person: robert keogh
Telephone: +353 014096598
E-mail: robert.keogh@olhsc.ie
Internet address(es):
Main address: www.chi.ie
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/384

I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Rituximab or biosimilar
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

We are seeking bids from suitably licensed organisations for the provision of Rituximab (originator or biosimilar) to Children’s Health Ireland.
II.1.6)

Information about lots

This contract is divided into lots: no
II.1.7)

Total value of the procurement

Value excluding VAT:  175000.00  EUR
II.2)

Description

II.2.2)

Additional CPV code(s)

33600000  -  Pharmaceutical products
II.2.3)

Place of performance

Main site or place of performance:  
CHI at Crumlin and Temple St
II.2.4)

Description of the procurement

We are seeking bids from suitably licensed organisations for the provision of Rituximab (originator or biosimilar) to Children’s Health Ireland.
II.2.5)

Award criteria

Criteria below
Quality criterion  -  Name:  Quality of Supply  /  Weighting:  20%
Quality criterion  -  Name:  Quality and Fitness for Purpose  /  Weighting:  20%
Quality criterion  -  Name:  Value Add  /  Weighting:  5%
Price  -  Weighting:  55%
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.1)

Previous publication concerning this procedure

Notice number in the OJ S: 2019/S 231-565917

Section V: Award of contract

Title: Rituximab Biosimilar

A contract/lot is awarded: yes
V.2)

Award of contract

V.2.1)

Date of conclusion of the contract

26/02/2020
V.2.2)

Information about tenders

Number of tenders received:  1
The contract has been awarded to a group of economic operators :  no
V.2.3)

Name and address of the contractor

Mundipharma
Millbank House
Dublin
18
IE

The contractor is an SME : no
V.2.4)

Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:  260000.00  EUR
Lowest offer:  173000.00  EUR / Highest offer:  173000.00  EUR   taken into consideration

Section VI: Complementary information

VI.4)

Procedures for review

VI.4.1)

Review body

Irish High Court
Dublin
Dublin
IE